• Pfizer Press Releases
• Information for Journalists
  • Multimedia Library
  • Calendar of Events
  • Contact Pfizer Media Relations
• Press Kit

Contact Pfizer Media Relations

This information is intended for media professionals.

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

If you are not a journalist, please visit the Contact Page and consult the appropriate Pfizer contact.

Phone: (212) 573-1226

Email Pfizer Media Relations

For specific media inquiries:
Europe/Africa/Middle East, email wwce@pfizer.com

You can also visit our Pfizer Worldwide Web Sites.

Contact	Responsibility	Key Products/Issues (not inclusive)
Ray Kerins W: 212-733-9203 C: 917-324-0080 Ray.Kerins@pfizer.com	Global Head of Media Relations
Vanessa Aristide W: 212-733-3784 C: 917-697-0481 Vanessa.Aristide@pfizer.com	Cardiovascular; Metabolic and Oncology	Lipitor, Exubera, Sutent
Jack Cox W: 212-733-5017 C: 917-514-2858 Jack.Cox@pfizer.com	Central Nervous System; Pain	Aricept, Geodon, Lyrica
Sally Beatty W: 212-733-6566 C: 347-330-7867 Sally.Beatty@pfizer.com	Urology; Respiratory; Anti-infective	Chantix, Viagra, Selzentry/Celsentri
Chris Loder W: 212-733-7897 C: 347-453-8199 Christopher.Loder@pfizer.com	Litigation; Policy; Manufacturing	Trovan (case in Nigeria), Cox-2 litigation, Counterfeiting
Shreya Jani W: 212-733-4889 C: 917-743-4349 Shreya.Jani@pfizer.com	Finance; Earnings/SEC filings; Corporate Governance; Business Development; HIV/AIDS	Earnings releases, Acquisitions, Business Deals
Liz Power W: 860-732-4987 C: 860-501-3849 Elizabeth.Power@pfizer.com	PGRD, BBC, Pipeline
Imraan Munshi W: 212-733-6197 C: 917-208-3021 Imraan.Munshi@pfizer.com	Asia/Japan, Canada
Oliver Stohlmann W: 43 1 52115 337 C: 43 664 3350485 Oliver.Stohlmann@pfizer.com	Europe	EU/local corporate, Lipitor, Champix, Oncology, COX-2, all brands
Lisa O'Neill W: 44 1737 331536 C: 44 7967 756924 Lisa.O'Neill@pfizer.com	Europe	R&D/science, Viagra, Lyrica, Aricept, CNS, Ophthalmology, Counterfeit Medicines
Bernard Peyrical C: 33 670 169505 Bernard.Peyrical@pfizer.com	Europe	European policy, HIV and Infectiology, Urology, Oncology
Gulden Mesara W: 902 1231 07521 C: 905 3246 79904 Gulden.Mesara@pfizer.com	Africa, Middle East
Francisco Gebauer W: 212-733-5191 C: 917-912-7688 Francisco.Gebauer@pfizer.com	Latin America
Rick Chambers W: 269-833-6387 C:269-760-0770 Richard.T.Chambers@pfizer.com	U.S. West	Marketing/Business Practices
Huw Gilbert W: 212-733-8926 C: 347-229-4560 Huw.Gilbert@pfizer.com	U.S. East	Marketing/Business Practices
Rick Goulart W: 212-733-7457 C: 860-501-3391 Rick.Goulart@pfizer.com	Animal Health

Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

A

B-D

E-H

I-N

O-P

R-Z

A-B

C

D-E

F-L

M-P

R-U

V-Z